ADCLEC.syn1

· Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADCLEC.syn1, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia [Phase 1]